Overview of Pain Management

Pain Practice

Volumn 4, Issue , 2004, Pages S4-S18

  Schim, Jack D ^a   Stang, Paul ^b  

^a North County Neurological Associates   (United States)

^b Galt Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; CORTICOSTEROID; DEXTROMETHORPHAN; DIZOCILPINE; ERGOT ALKALOID; GABAPENTIN; INDOMETACIN; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; PHENYTOIN; PROPOFOL; PROSTAGLANDIN SYNTHASE INHIBITOR; TRAMADOL; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VENLAFAXINE;

ALTERNATIVE MEDICINE; ANALGESIA; ANGINA PECTORIS; ANTINOCICEPTION; ARTHRITIS; ARTICLE; BACKACHE; BRAIN CORTEX; CHRONIC PAIN; DEMOGRAPHY; DIABETIC NEUROPATHY; DISEASE CLASSIFICATION; DRUG ABUSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIDURAL ANESTHESIA; HEALTH CARE COST; HUMAN; INFLAMMATION; JOB PERFORMANCE; LOW BACK PAIN; NERVE BLOCK; NEURALGIA; NEUROANATOMY; NEUROLYSIS; NEUROPATHY; NONSURGICAL INVASIVE THERAPY; OSTEOARTHRITIS; PATHOGENESIS; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PREVALENCE; QUALITY OF LIFE; RECURRENT DISEASE; RHIZOTOMY; SENSITIZATION; SENSORY NERVE; SOCIOECONOMICS; THALAMUS; TRIGEMINUS NEURALGIA; UNITED STATES;

EID: 34447256748     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2004.04010.x     Document Type: Article

References (126)

1. Katz WA. Musculoskeletal pain and its socioeconomic implications. Clin Rheumatol. 2002;21(suppl 1):S2-S4.
2. American Chronic Pain Association. Pain fact sheet. Available at: http://www.theacpa.org/pain_fact_sheet.asp. Accessed July 31, 2003.
3. Blomqvist K. Older people in persistent pain: nursing and paramedical staff perceptions and pain management. J Adv Nurs. 2003;41: 575-584.
4. Becker K. Facts about pain in America. Available at: http://www.edc.org/PainLink/plfctr.html. Accessed July 31, 2003.
5. Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract. 2001;14: 178-183.
6. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999;354: 1248-1252.
7. Curtiss CP. JCAHO: meeting the standards for pain management. Orthopaedic Nursing. 2001;20: 27-30.
8. Doheny, Kathleen. Pain conditions cost $80 billion annually in lost productivity. Available at: http://www.spinalrehab.com.au/Updates/Pain/Conditions/Cost/$80/Billion/Annually/in/Lost/Productivity.htm. Accessed September 12, 2003.
9. Sipkoff M. Pain presents challenges for MCOs. Available at: http://www.qiphysician.com/cgi-bin/article.cgi?article_id=1220. Accessed July 31, 2003.
10. Blyth FM, March LM, Nicholas MK, Cousins MJ. Chronic pain, work performance and litigation. Pain. 2003;103: 41-47.
11. Rizzo JA, Abbott TA, III, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care. 1998;36: 1471-1488.
12. Becker N, Bondegaard Thomsen A, Olsen AK, Sjøgren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997;73: 393-400.
13. American Pain Society. Chronic pain in America: roadblocks to relief. Available at: http://www.ampainsoc.org/whatsnew/summary1_road.htm. Accessed August 5, 2003.
14. Jacobson L, Mariano AJ. General considerations of chronic pain. In: Loeser JD, Butler SH, Chapman CR, Turk DC, eds. Bonica's Management of Pain. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 241-254.
15. American Academy of Family Physicians 2003. Pain: the basics. Available at: http://members.aafp.org/hssa/cgi-bin/quiz.pl?op=show_quiz&gid=1075. Accessed July 31, 2003.
16. Bedard ME. Fact sheet on chronic nonmalignant pain (CNP). Available at: http://www.druglibrary.org/schaffer/asap/factsheet.html. Accessed July 31, 2003.
17. McIntosh A, Shaw CFM. Barriers to patient information provision in primary care: patients' and general practitioners' experiences and expectations of information for low back pain. Health Expect. 2003;6: 19-29.
18. Glenton C. Developing patient-centred information for back pain sufferers. Health Expect. 2002;5: 319-329.
19. Task Force on Taxonomy of the International Association for the Study of Pain. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Second ed. Seattle, WA: IASP Press; 1994.
20. Cole BE. Pain management: classifying, understanding, and treating pain. Hospital Physician. 2003;23-30.
21. Kuner R. Nociception. Available at: http://encref.springer.de/mp/0002.htm. Accessed August 5, 2003.
22. Queen Mary's School of Medicine and Dentistry, Univerity of London (QMUL). Review of pain & analgesia. Available at: http://www.mds.qmul.ac.uk/biomed/kb/brain&behaviour/pain.htm. Accessed July 31, 2003.
23. Dunajcik L. Chronic nonmalignant pain. In: McCaffery M, Pasero C, eds. Pain Clinical Manual. St. Louis, MO: Mosby, Inc.; 1999: 467-521.
24. Benjamin S, Barnes D, Berger S, Clarke I, Jeacock J. The relationship of chronic pain, mental illness and organic disorders. Pain. 1988;32: 185-195.
25. Katz J. Pain in public and private places. Pain Forum. 1995;4: 19-22.
26. Asmundson GJ, Jacobson SJ, Allerdings MD, Norton GR. Social phobia in disabled workers with chronic musculoskeletal pain. Behav Res Ther. 1996;34: 939-943.
27. Goucke CR. The management of persistent pain. Med J Aust. 2003;178: 444-447.
28. Spruce MC, Potter J, Coppini DV. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med. 2003;20: 88-98.
29. Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18: 343-349.
30. Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes. Neurology. 2002;59(suppl 2):S2-S7.
31. Pain. In: Purves D, Augustine GJ, Fitzpatrick D, et al, eds. Neuroscience. Sunderland, MA: Sinauer Associates, Inc.; 2001: 209-222.
32. Bushnell MC, Duncan GH, Hofbauer RK, Ha B, Chen J-I, Carrier B. Pain perception: is there a role for primary somatosensory cortex? Proc Natl Acad Sci USA. 1999;96: 7705-7709.
33. Tölle TR, Kaufmann T, Siessmeier T, et al. Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol. 1999;45: 40-47.
34. McHugh JM, McHugh WB. Pain: neuroanatomy, chemical mediators, and clinical implications. AACN Clin Issues. 2000;11: 168-178.
35. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis. 1998;5: 209-227.
36. Michaelis M, Janig W. Sympathetic nervous system and pain: pathophysiological mechanisms [German]. Schmerz. 1998;12: 261-271.
37. Willis WD, Jr. Role of neurotransmitters in sensitization of pain responses. Ann NY Acad Sci. 2001;933: 142-156.
38. Attal N, Bouhassira D. Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand Suppl. 1999;173: 12-24.
39. Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain. 2000;16(2 suppl):S73-S79.
40. Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin J Pain. 2000;16: S118-S130.
41. + currents in rat sensory neurons. Anesthesiology. 2001;94: 137-144.
42. Chen SR, Xu Z, Pan HL. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiology. 2001;95: 1473-1479.
43. Karmakar MK, Ho AM. Acute pain management of patients with multiple fractured ribs. J Trauma. 2003;54: 615-625.
44. Neal JM, McDonald SB, Larkin KL, Polissar NL. Suprascapular nerve block prolongs analgesia after nonarthroscopic shoulder surgery but does not improve outcome. Anesth Analg. 2003;96: 982-986.
45. Ilfeld BM, Morey TE, Wright TW, Chidgey LK, Enneking FK. Continuous interscalene brachial plexus block for postoperative pain control at home: a randomized, double-blinded, placebo-controlled study. Anesth Analg. 2003;96: 1089-1095.
46. Wasner G, Schattschneider J, Binder A, Baron R. Complex regional pain syndrome-diagnostic, mechanisms, CNS involvement and therapy. Spinal Cord. 2003;41: 61-75.
47. Gale G, Nussbaum D, Rothbart P, Hann B, Leung V, Kanetz G. A randomized treatment study to compare the efficacy of repeated nerve blocks with cognitive therapy for control of chronic head and neck pain. Pain Res Manag. 2002;7: 185-189.
48. Pham-Dang C, Kick O, Collet T, Gouin F, Pinaud M. Continuous peripheral nerve blocks with stimulating catheters. Reg Anesth Pain Med. 2003;28: 83-88.
49. Aldrete JA. Epidural injections of indomethacin for postlaminectomy syndrome: a preliminary report. Anesth Analg. 2003;96: 463-468, table.
50. Halpern SH, Breen TW, Campbell DC, et al. A multicenter, randomized, controlled trial comparing bupivacaine with ropivacaine for labor analgesia. Anesthesiology. 2003;98: 1431-1435.
51. Allan CY, Jacqueline PA, Shubhda JH. Caudal epidural block versus other methods of postoperative pain relief for circumcision in boys. Cochrane Database Syst Rev. 2003;CD003005.
52. Sendil D, Bonney IM, Carr DB, Lipkowski AW, Wise DL, Hasirci V. Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats. Biomaterials. 2003;24: 1969-1976.
53. Ogun CO, Kirgiz EN, Duman A, Okesli S, Akyurek C. Comparison of intrathecal isobaric bupivacaine-morphine and ropivacaine-morphine for Caesarean delivery. Br J Anaesth. 2003;90: 659-664.
54. Mahli A, Coskun D, Altun NS, Simsek A, Ocal E, Kostekci M. Alcohol neurolysis for persistent pain caused by superior cluneal nerves injury after iliac crest bone graft harvesting in orthopedic surgery: report of four cases and review of the literature. Spine. 2002;27: E478-E481.
55. Jiang D, Yu X, An H, Liang Y, Liang A. Hip and pelvic fractures and sciatic nerve injury. Chin J Traumatol. 2002;5: 333-337.
56. Slatkin NE, Rhiner M. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care. 2003;20: 62-66.
57. Soysal ME, Soysal S, Gurses E, Ozer S. Laparoscopic presacral neurolysis for endometriosis-related pelvic pain. Hum Reprod. 2003;18: 588-592.
58. Adler DG, Romero Y. Primary esophageal motility disorders. Mayo Clin Proc. 2001;76: 195-200.
59. Fabinyi G, Dutton J. The surgical treatment of spasmodic torticollis. Aust N Z J Surg. 1980;50: 155-157.
60. Camu F, Vanlersberghe C. Pharmacology of systemic analgesics. Best Pract Res Clin Anaesthesiol. 2002;16: 475-488.
61. Kvien TK, Viktil K. Pharmacotherapy for regional musculoskeletal pain. Best Pract Res Clin Rheumatol. 2003;17: 137-150.
62. Malan TP, Jr., Marsh G, Hakki SI, Grossman E, Traylor L, Hubbard RC. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology. 2003;98: 950-956.
63. Recart A, Issioui T, White PF, et al. The efficacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: a dose-ranging study. Anesth Analg. 2003;96: 1631-1635, table.
64. Ruoff G, Lema M. Strategies in pain management: new and potential indications for COX-2 specific inhibitors. J Pain Symptom Manage. 2003;25(2 suppl):S21-S31.
65. Watcha MF, Issioui T, Klein KW, White PF. Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery. Anesth Analg. 2003;96: 987-994.
66. Fishbain DA. Analgesic effects of antidepressants. J Clin Psychiatry. 2003;64: 96-97.
67. Carter GT, Sullivan MD. Antidepressants in pain management. Curr Opin Investig Drugs. 2002;3: 454-458.
68. Mattia C, Paoletti F, Coluzzi F, Boanelli A. New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol. 2002;68: 105-114.
69. Zhou S, Bonasera L, Carlton SM. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport. 1996;7: 895-900.
70. Woolf CJ. Windup and central sensitization are not equivalent [editorial]. Pain. 1996;66: 105-108.
71. McKenna JE, Melzack R. Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces anal-gesia in the formalin pain test. Exp Neurol. 2001;172: 92-99.
72. Berrino L, Oliva P, Massimo F, et al. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur J Pain. 2003;7: 131-137.
73. Warncke T, Stubhaug A, Jørum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 1997;72: 99-106.
74. Piotrowski W, Foreman JC. Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol. 1986;114: 37-46.
75. Lohmann AB, Welch SP. Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception. Eur J Pharmacol. 1999;384: 147-152.
76. Fukunaga AF, Alexander GE, Stark CW. Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain. 2003;101: 129-138.
77. Kowaluk EA, Mikusa J, Wismer CT, et al. ABT-70-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J Pharmacol Exp Ther. 2000;295: 1165-1174.
78. Pandey CK, Bose N, Garg G, et al. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg. 2002;95: 1719-1723.
79. Vickers ER, Cousins MJ. Neuropathic orofacial pain part 1-prevalence and pathophysiology. Aust Endod J. 2000;26: 19-26.
80. Miyoshi HR, Leckband SG. Systemic opioid analgesics. In: Loeser JD, ed. Bonica's Management of Pain. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 1682-1709.
81. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60: 139-176.
82. Bricker L, Lavender T. Parenteral opioids for labor pain relief: a systematic review. Am J Obstet Gynecol. 2002;186: S94-S109.
83. Reuben SS, Sklar J. Intravenous regional anesthesia with clonidine in the management of complex regional pain syndrome of the knee. J Clin Anesth. 2002;14: 87-91.
84. Aveline C, El Metaoua S, Masmoudi A, Boelle PY, Bonnet F. The effect of clonidine on the minimum local analgesic concentration of epidural ropivacaine during labor. Anesth Analg. 2002;95: 735-740, table.
85. Bonhomme V, Doll A, Dewandre PY, Brichant JF, Ghassempour K, Hans P. Epidural administration of low-dose morphine combined with clonidine for postoperative analgesia after lumbar disc surgery. J Neurosurg Anesthesiol. 2002;14: 1-6.
86. Jeffs SA, Hall JE, Morris S. Comparison of morphine alone with morphine plus clonidine for postoperative patient-controlled analgesia. Br J Anaesth. 2002;89: 424-427.
87. Keam S, Goa K, Figgitt D. Almotriptan: a review of its use in migraine. Headache. 2003;43: 300-301.
88. Mondell BE. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine. Clin Ther. 2003;25: 331-341.
89. Christie S, Gobel H, Mateos V, Allen C, Vrijens F, Shivaprakash M. Crossover comparison of efficacy and preference for rizatriptan 10mg versus ergotamine/caffeine in migraine. Eur Neurol. 2003;49: 20-29.
90. Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treat-ment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol. 2002;47: 99-107.
91. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology. 2000;55: 915-920.
92. Boelsterli UA. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf. 2002;25: 633-648.
93. Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain. 2002;18(6 suppl):S147-S154.
94. Haeseler G, Tetzlaff D, Bufler J, et al. Blockade of voltage-operated neuronal and skeletal muscle sodium channels by S(+)- and R(-)-ketamine. Anesth Analg. 2003;96: 1019-1026.
95. Classey JD, Knight YE, Goadsby PJ. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res. 2001;907: 117-124.
96. Svendsen F, Tjølsen A, Hole K. AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation. Neuroreport. 1998;9: 1185-1190.
97. Stichtenoth DO, Frölich JC. The second generation of COX-2 inhibitors: what advantages do the newest offer? Drugs. 2003;63: 33-45.
98. Schnitzer TJ. Non-NSAID pharmacologic treatment options for the management of chronic pain. Am J Med. 1998;105: 45S-52S.
99. Thomas S, Bruce C, Birkhead A, Wang L. Effect of ecNOS polymorphisms and coronary artery disease upon exhaled nitric oxide. J Mol Med. 2002;80: 181-186.
100. Srikiatkhachorn A, Anuntasethakul T, Maneesri S, Phansuwan-Pujito P, Patumraj S, Kasantikul V. Hyposerotonin-induced nitric oxide supersensitivity in the cerebral microcirculation. Headache. 2000;40: 267-275.
101. Önal A, Delen Y, Ülker S, Soykan N. Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci. 2003;73: 413-428.
102. Burgaud JL, Riffaud JP, Del Soldato P. Nitric-oxide releasing molecules: a new class of drugs with several major indications. Curr Pharm Des. 2002;8: 201-213.
103. Benkusky NA, Lewis SJ, Kooy NW. Attenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite in vivo. Am J Physiol. 1998;275: H501-H508.
104. Christiansen I, Iversen HK, Olesen J. Headache characteristics during the development of tolerance to nitrates: pathophysiological implications. Cephalalgia. 2000;20: 437-444.
105. Costa A, Ravaglia S, Sances G, Antonaci F, Pucci E, Nappi G. Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels. Cephalalgia. 2003;23: 407-413.
106. 2+ current in hippocampal and dorsal root ganglion neurons of the rat. Mol Pharmacol. 1998;54: 559-568.
107. Almeida T, Roizanblatt S, Benedito-Silva A, Tufik S. The effect of combined therapy (ultrasound and interferential current) on pain and sleep in fibromyalgia. Pain 2003;104: 665-672.
108. Brown J, Barbaro N. Motor cortex stimulation for central neuropathic pain: current status. Pain 2003;104: 431-435.
109. Koo ST, Park YI, Lim KS, Chung K, Chung JM. Acupuncture analgesia in a new rat model of ankle sprain pain. Pain. 2002;99: 423-431.
110. Hong CZ. New trends in myofascial pain syndrome. Chin Med J (Taipei). 2002;65: 501-512.
111. Thabrew MI, Dharmasiri MG, Senaratne L. Anti-inflammatory and analgesic activity in the polyherbal formulation Maharasnadhi Quathar. J Ethnopharmacol. 2003;85: 261-267.
112. Strichartz GR, Zhou Z, Sinnott C, Khodorova A. Therapeutic concentrations of local anaesthetics unveil the potential role of sodium channels in neuropathic pain. Novartis Found Symp. 2002;241: 189-201.
113. Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am. 2001;12: 447-459.
114. Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003;43: 111-117.
115. Hautkappe M, Roizen MF, Toledano A, Roth S, Jeffries JA, Ostermeier AM. Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J Pain. 1998;14: 97-106.
116. Bruhlmann P, Michel BA. Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol. 2003;21: 193-198.
117. Bjorkman DJ. The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am J Med. 1998;105: 8S-12S.
118. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000;19: 287-294.
119. Colak T, Ipek T, Kanik A, Ogetman Z, Aydin S. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg. 2003;196: 525-530.
120. ® cream and oral glucose for immunization pain in 3-month-old infants. Pain 2003;104: 381-388.
121. Uziel Y, Berkovitch M, Gazarian M, et al. Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial. J Rheumatol. 2003;30: 594-596.
122. Machen J, Whitefield M. Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study. Int J Clin Pract. 2002;56: 102-106.
123. Wetzel D, Menke W, Dieter R, Smasal V, Giannetti B, Bulitta M. Escin/diethylammonium salicylate/heparin combination gels for the topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br J Sports Med. 2002;36: 183-188.
124. Truong W, Cheng C, Xu Q-G, Li X-Q, Zochodne DW. μ opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol. 2003;53: 366-375.
125. Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med. 2001;15: 309-321.
126. Ringe JD, Faber H, Bock O, et al. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int. 2002;22: 199-203.